Urinalysis

Universal early-age urinalysis may be an apt means for both better prognoses and reduced costs of medical care

Unveiled at ADLM 2025, Copan's UriVerse™ streamlines preanalytical steps like aliquoting, labeling, and capping to boost lab efficiency and accuracy

Results from the first cohort of the AURORAX 087A study show the new biomarker-based test provides a more robust basis for making decisions on treatment than scans alone

The test could enable at-home testing and increased access to testing for patients undergoing telehealth care or living in remote areas

Analyzing RNA in urine for cell changes may allow some individuals to avoid invasive biopsies

Sysmex products on display throughout the ADLM Clinical Lab Expo at Booth #413 in Chicago—press conference on July 30 at 10:00 a.m. in room s103A

 Studies suggest that shorter PFAS may easily find their way into homes and are more toxic than PFOS and PFOA

Simple, noninvasive, accurate, and robust urine test uses aberrantly methylated genes as a biomarker

Estrogen may also play a role in reducing UTI susceptibility in women

A new study is the first to identify formic acid as a sensitive urinary biomarker of early-stage Alzheimer’s disease